Search the Newsreel

Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities. The investigation concerns whether Phreesia and its officers and/or directors engaged in corporate wrongdoing. Investors who bought Phreesia securities before March 30, 2026, and still …

PHR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Phreesia, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) for alleged violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing …

Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of "Hold" by Brokerages

Phreesia, Inc. (NYSE:PHR) has received a consensus "Hold" rating from 19 brokerages, with an average 12-month price target of $16.65. Recent analyst updates show mixed views, with some firms lowering price targets while others maintained buy ratings. The company's latest quarterly earnings exceeded expectations, …

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.5 per share a year ago. These figures are adjusted for non-recurring items. This …

Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP reduced its stake in Phreesia, Inc. (NYSE:PHR) by 22.9% in the first quarter, selling 143,563 shares and retaining 484,717 shares valued at $4.07 million. Despite this reduction, institutional investors collectively own 92.1% of the company. Phreesia reported strong Q1 earnings …

AQR Capital discloses 5.1% Phreesia (PHR) ownership in new Schedule 13G

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5.1% in Phreesia, Inc. (PHR) through a new Schedule 13G filing. This amounts to 3,151,453 shares of common stock, with both entities sharing voting and dispositive power. The …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities who bought prior to March 30, 2026, and still hold their shares. The investigation focuses on whether Phreesia and its officers/directors engaged in corporate wrongdoing. …

Phreesia Inc (PHR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Phreesia Inc (PHR), detailing its current earnings forecast score, average price target from analysts, and a breakdown of analyst ratings. It also includes key financial figures such as expected revenue and EPS for upcoming quarters, alongside a …

Phreesia Inc (PHR) Stock News Today

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Phreesia, Inc. (NYSE:PHR) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to learn more …

Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026. Phreesia will issue a press release announcing its quarterly …

Phreesia schedules Sept. 2 call to discuss fiscal Q2 results

PHR Stockholders Have Opportunity to Lead Phreesia, Inc. Class Ac

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and certain officers, alleging federal securities law violations. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments …

PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT:

Bernstein Liebhard LLP is investigating potential breaches of fiduciary duty by directors and officers of Phreesia, Inc. (NYSE: PHR). The firm encourages current Phreesia shareholders who purchased shares before May 8, 2025, to contact them to learn about their legal rights. The investigation aims …

PHR Stockholders Have Rights – If You Lost Money Investing in Phreesia, Inc.

Robbins LLP has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors about the sustainability of its Network Solutions business growth …

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 23% Upside Potential Amid Robust Revenue Growth

Phreesia, Inc. (NYSE: PHR) director takes fee as 377 deferred stock units

Phreesia, Inc. director Lainie Goldstein received 377 deferred stock units (DSUs) on July 31, 2026, as an equity-based director fee in lieu of a cash retainer. These DSUs, valued at $10.73 per share, increase her direct holdings to 70,862 shares. The underlying common stock …

Phreesia (PHR) director takes 685 deferred stock units over cash

Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Phreesia, Inc. (NYSE: PHR). The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to contact them for more information and to …

How Phreesia Inc. (PHR) Affects Rotational Strategy Timing

This article analyzes Phreesia Inc. (PHR) using AI models to determine its impact on rotational strategy timing. It highlights key findings including shifting near-term sentiment, broader weak alignment, and compelling upside potential due to a lack of resistance levels. The analysis also provides three …

Phreesia Number of Employees 2026 | Employee Count & Headcount Data

Phreesia, Inc. (PHR) had approximately 1,778 total employees worldwide as of March 2026, marking a 7.1% decline from 1,914 employees in 2023. The company, which is in the Biotech and Healthcare Services industry, is actively hiring with 57 job postings in 2026, despite a …

PHR|Phreesia Inc|Price:10.740|Chg%:+0.130

Phreesia Inc (PHR) shows relatively healthy fundamentals with high growth potential, and its valuation is considered fairly valued. Despite average stock market performance, the company has turned profitable, and institutional ownership is very high. Analysts have rated it as a Buy, expecting an upward …

Law firm investigates Phreesia directors for possible breaches of fiduciary duty

Bernstein Liebhard LLP is investigating whether Phreesia, Inc.'s directors and officers breached their fiduciary duties to shareholders. The investigation seeks to determine if the company's leadership acted in the best interests of shareholders and if legal action against them is warranted. Shareholders who purchased …

PHR|Phreesia Inc|Price:10.930|

This article provides an in-depth analysis of Phreesia Inc (PHR) stock, highlighting its market trends, key figures, and analyst ratings. The company, which offers comprehensive software solutions for healthcare organizations, shows healthy fundamentals and high growth potential. Despite average stock performance over the last …

Phreesia Inc (PHR) Income Statement

This article presents the quarterly and annual income statements for Phreesia Inc (PHR), detailing financial performance metrics such as total revenue, cost of revenue, operating expenses, and net income over various fiscal periods. It also includes key financial figures for recent quarters and fiscal …

Phreesia Inc (PHR) Balance Sheet

This article provides a detailed balance sheet analysis for Phreesia Inc (PHR), presenting annual and quarterly financial data from FY2020Q1 through FY2027Q1. It breaks down current and non-current assets and liabilities, shareholders' equity, and includes key financial metrics like cash and equivalents, receivables, total …

Phreesia Inc (PHR) Cash Flow

This article provides a detailed overview of Phreesia Inc.'s (PHR) cash flow statements, including operating, investing, and financing activities. It presents quarterly and annual data with year-over-year changes for various cash flow components. The content also defines key cash flow metrics like operating cash …

PHR|Phreesia Inc|Price:10.220|Chg%:+0.435

This article provides a detailed company profile for Phreesia Inc (PHR), a provider of healthcare software solutions. It covers the company's business scope, financial data, market performance, and executive information. Phreesia offers SaaS-based tools for patient access, registration, payments, and clinical assessments, aiming to …

Phreesia Inc (PHR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Phreesia Inc (PHR), outlining its major shareholders, institutional holdings, and related ETFs. It provides a breakdown of shareholder types, institutional activity over several quarters, and a list of top shareholders with their respective holdings and changes.

PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce that Phreesia, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) and certain officers for alleged violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened …

Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies

This new collaboration reaches patients and their providers with information on widespread, preventable maternal health conditions ALL-REMOTE COMPANY/WILMINGTON, Del., July 23, 2026--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation that enables one in six patient visits across the U.S., and March of …

Preeclampsia and Postpartum Depression Resources Reach Patients Before Visits

Phreesia and March of Dimes have partnered to provide timely, evidence-based educational resources to new parents, caregivers, and healthcare providers to improve maternal and infant health outcomes. This collaboration focuses on raising awareness and providing information on preeclampsia, postpartum depression, and safe sleep practices …

Phreesia Launches AI Chatbot to Connect Patients With Healthcare Providers

Phreesia has launched an AI-powered chatbot designed to streamline patient-provider connections. The new tool aims to improve the healthcare experience by facilitating easier access and communication. This development highlights Phreesia's ongoing efforts to integrate advanced technology into its platform to enhance patient engagement.